First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Soria, Jean-Charles, Prof, Tan, Daniel S W, MD, Chiari, Rita, MD, Wu, Yi-Long, Prof, Paz-Ares, Luis, Prof, Wolf, Juergen, Prof, Geater, Sarayut L, MD, Orlov, Sergey, Prof, Cortinovis, Diego, MD, Yu, Chong-Jen, Prof, Hochmair, Maximillian, MD, Cortot, Alexis B, Prof, Tsai, Chun-Ming, Prof, Moro-Sibilot, Denis, MD, Campelo, Rosario G, MD, McCulloch, Tracey, MSc, Sen, Paramita, PhD, Dugan, Margaret, MD, Pantano, Serafino, PhD, Branle, Fabrice, MD, Massacesi, Cristian, MD, de Castro, Gilberto, MD
Published in The Lancet (British edition) (04.03.2017)
Published in The Lancet (British edition) (04.03.2017)
Get full text
Journal Article
Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL
Kantarjian, Hagop, Giles, Francis, Wunderle, Lydia, Bhalla, Kapil, O'Brien, Susan, Wassmann, Barbara, Tanaka, Chiaki, Manley, Paul, Rae, Patricia, Mietlowski, William, Bochinski, Kathy, Hochhaus, Andreas, Griffin, James D, Hoelzer, Dieter, Albitar, Maher, Dugan, Margaret, Cortes, Jorge, Alland, Leila, Ottmann, Oliver G
Published in The New England journal of medicine (15.06.2006)
Published in The New England journal of medicine (15.06.2006)
Get full text
Journal Article
Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
Ellis, Leigh, Pan, Yan, Smyth, Gordon K, George, Daniel J, McCormack, Chris, Williams-Truax, Roxanne, Mita, Monica, Beck, Joachim, Burris, Howard, Ryan, Gail, Atadja, Peter, Butterfoss, Dale, Dugan, Margaret, Culver, Kenneth, Johnstone, Ricky W, Prince, H Miles
Published in Clinical cancer research (15.07.2008)
Published in Clinical cancer research (15.07.2008)
Get full text
Journal Article
A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients with Refractory Hematologic Malignancies
GILES, Francis, FISCHER, Thomas, KANTARJIAN, Hagop, DUGAN, Margaret, ALBITAR, Maher, BHALLA, Kapil, CORTES, Jorge, GARCIA-MANERO, Guillermo, BECK, Joachim, RAVANDI, Farhad, MASSON, Eric, RAE, Patricia, LAIRD, Glen, SHARMA, Sunil
Published in Clinical cancer research (01.08.2006)
Published in Clinical cancer research (01.08.2006)
Get full text
Journal Article
ACTIVE (Ability Captured Through Interactive Video Evaluation) workspace volume video game to quantify meaningful change in spinal muscular atrophy
Alfano, Lindsay N, Miller, Natalie F, Iammarino, Megan A, Moore Clingenpeel, Melissa, Lowes, Suzanne L, Dugan, Margaret E, Kissel, John T, Al Zaidy, Samiah, Tsao, Chang‐Yong, Lowes, Linda P
Published in Developmental medicine and child neurology (01.03.2020)
Published in Developmental medicine and child neurology (01.03.2020)
Get full text
Journal Article
Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
LHOMME, Catherine, JOLY, Florence, JONES, Gary J, DUGAN, Margaret H, WALKER, Joan L, LISSONI, Andrea A, NICOLETTO, Maria O, MANIKHAS, Gregory M, BAEKELANDT, Mark M. O, GORDON, Alan N, FRACASSO, Paula M, MIETLOWSKI, William L
Published in Journal of clinical oncology (01.06.2008)
Published in Journal of clinical oncology (01.06.2008)
Get full text
Journal Article
Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I Studies
MORGAN, Bruno, THOMAS, Anne L, MIETLOWSKI, William, FUXIUS, Stefan, UNGER, Clemens, O'BYRNE, Ken, HENRY, Andrew, CHERRYMAN, Graham R, LAURENT, Dirk, DUGAN, Margaret, MARME, Dieter, STEWARD, William P, DREVS, Joachim, HENNIG, Juergen, BUCHERT, Martin, JIVAN, Asvina, HORSFIELD, Mark A, MROSS, Klauss, BALL, Howard A, LEE, Lucy
Published in Journal of clinical oncology (01.11.2003)
Published in Journal of clinical oncology (01.11.2003)
Get full text
Journal Article
Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial
ELLIS, Matthew J, COOP, Andrew, QUEBE-FEHLING, Erhard, BORGS, Mieke, SINGH, Baljit, MAURIAC, Louis, LLOMBERT-CUSSAC, Antonio, JÄNICKE, Fritz, MILLER, William R, EVANS, Dean B, DUGAN, Margaret, BRADY, Carolyn
Published in Journal of clinical oncology (15.09.2001)
Published in Journal of clinical oncology (15.09.2001)
Get full text
Journal Article
AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has In vitro Activity against Imatinib-Resistant Chronic Myeloid Leukemia
GOLEMOVIC, Mirna, VERSTOVSEK, Srdan, ARLINGHAUS, Ralph B, TONG SUN, KANTARJIAN, Hagop, BERAN, Miloslav, GILES, Francis, CORTES, Jorge, MANSHOURI, Taghi, MANLEY, Paul W, MESTAN, Jürgen, DUGAN, Margaret, ALLAND, Leila, GRIFFIN, James D
Published in Clinical cancer research (01.07.2005)
Published in Clinical cancer research (01.07.2005)
Get full text
Journal Article
Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
Mouridsen, H, Gershanovich, M, Sun, Y, Pérez-Carrión, R, Boni, C, Monnier, A, Apffelstaedt, J, Smith, R, Sleeboom, H P, Jänicke, F, Pluzanska, A, Dank, M, Becquart, D, Bapsy, P P, Salminen, E, Snyder, R, Lassus, M, Verbeek, J A, Staffler, B, Chaudri-Ross, H A, Dugan, M
Published in Journal of clinical oncology (15.05.2001)
Published in Journal of clinical oncology (15.05.2001)
Get full text
Journal Article
Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse
Yung, W.K. Alfred, Prados, Michael D., Yaya-Tur, Ricardo, Rosenfeld, Steven S., Brada, Michael, Friedman, Henry S., Albright, Robert, Olson, Jeffrey, Chang, Susan M., O'Neill, Alison M., Friedman, Allan H., Bruner, Janet, Yue, Nancy, Dugan, Margaret, Zaknoen, Sara, Levin, Victor A.
Published in Journal of clinical oncology (01.09.1999)
Published in Journal of clinical oncology (01.09.1999)
Get full text
Journal Article
AMN107, a novel aminopyrimidine inhibitor of p190 Bcr‐Abl activation and of in vitro proliferation of Philadelphia‐positive acute lymphoblastic leukemia cells
Verstovsek, Srdan, Golemovic, Mirna, Kantarjian, Hagop, Manshouri, Tashi, Estrov, Zeev, Manley, Paul, Sun, Tong, Arlinghaus, Ralph B., Alland, Leila, Dugan, Margaret, Cortes, Jorge, Giles, Francis, Beran, Miloslav
Published in Cancer (15.09.2005)
Published in Cancer (15.09.2005)
Get full text
Journal Article
Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib
La Rosee, Paul, Holm-Eriksen, Susanne, Konig, Heiko, Hartel, Nicolai, Ernst, Thomas, Debatin, Julia, Mueller, Martin C, Erben, Philipp, Binckebanck, Anja, Wunderle, Lydia, Shou, Yaping, Dugan, Margaret, Hehlmann, Ruediger, Ottmann, Oliver G, Hochhaus, Andreas
Published in Haematologica (Roma) (01.05.2008)
Published in Haematologica (Roma) (01.05.2008)
Get full text
Journal Article
Genetic landscape of ALK+ non-small cell lung cancer (NSCLC) patients (pts) and response to ceritinib in ASCEND-1
Tan, Daniel Shao-Weng, Kim, Dong-Wan, Thomas, Michael, Pantano, Serafino, Wang, Ying, Szpakowski, Sebastian Lukasz, Yovine, Alejandro Javier, Mehra, Ranee, Chow, Laura Q., Sharma, Sunil, Solomon, Benjamin J., Felip, Enriqueta, Camidge, D. Ross, Vansteenkiste, Johan F., Bitter, Hans, Petruzzelli, Lilli M., Dugan, Margaret Han, Shaw, Alice T.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies
HAMMOND, L. A, ECKARDT, J. R, VON HOFF, D. D, ROWINSKY, E. K, BAKER, S. D, ECKHARDT, S. G, DUGAN, M, FORRAL, K, REIDENBERG, P, STATKEVICH, P, WEISS, G. R, RINALDI, D. A
Published in Journal of clinical oncology (01.08.1999)
Published in Journal of clinical oncology (01.08.1999)
Get full text
Journal Article
Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial
Wong, Connie C, Baum, Jason, Silvestro, Angela, Beste, Michael T, Bharani-Dharan, Bharani, Xu, Siyan, Wang, Ying A, Wang, Xiaoshan, Prescott, Margaret F, Krajkovich, Lynne, Dugan, Margaret, Ridker, Paul M, Martin, Anne-Marie, Svensson, Eric C
Published in Cancer research (Chicago, Ill.) (15.12.2020)
Published in Cancer research (Chicago, Ill.) (15.12.2020)
Get full text
Journal Article
Glutamine antagonist DRP-104 in combination with durvalumab in patients with advanced fibrolamellar carcinoma (FLC) following progression on prior anti-PD(L)1 therapy
Nakazawa, Mari, Kamdar, Zeal, Thomas, Amy, Durham, Jennifer N., Nauroth, Julie, Wang, Hao, Ladle, Brian H., Dykstra, Steven, Dugan, Margaret, Lafleur, Francois, Furth, Mark E., Leone, Robert D., Jaffee, Elizabeth M., Yarchoan, Mark, Baretti, Marina
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Abstract 1572: Broad glutamine pathway inhibition by DRP-104 results in anti-tumor activity in hypermetabolic lung tumors resistant to PD-1 or osimertinib therapy
Brady, Morgan, Momcilovic, Milica, Montemurro, Chiara, Yokoyama, Yumi, Christofk, Heather, Politi, Katerina, Dugan, Margaret, Lisberg, Aaron, Wild, Robert, Shackelford, David B.
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
Arolt, Christoph, Dugan, Margaret, Wild, Robert, Richartz, Vanessa, Holz, Barbara, Scheel, Andreas H., Brägelmann, Johannes, Wagener-Ryczek, Svenja, Merkelbach-Bruse, Sabine, Wolf, Juergen, Buettner, Reinhard, Catanzariti, Luigi, Scheffler, Matthias, Hillmer, Axel M.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
Phase 1 and phase 2a, first-in-human (FIH) study, of DRP-104, a broad glutamine antagonist, in adult patients with advanced solid tumors
Johnson, Melissa Lynne, Doroshow, Deborah Blythe, Seiwert, Tanguy Y., Gibson, Michael K., Velcheti, Vamsidhar, Lisberg, Aaron Elliott, Patel, Shetal Arvind, Scheffler, Matthias, Lafleur, Francois, Dugan, Margaret Han, Sharma, Sunil
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article